Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-02 2:02 pm Purchase | 2023-12-31 | 13G | Neptune Wellness Solutions Inc. NEPT | SABBY MANAGEMENT, LLC | 452,751 11.000% | 425,353 (+1552.51%) | Filing History |
| 2024-01-02 1:45 pm Purchase | 2023-12-31 | 13G | ToughBuilt Industries, Inc. TBLT | SABBY MANAGEMENT, LLC | 1,842,070 11.000% | 1,823,125 (+9623.29%) | Filing History |
| 2024-01-02 1:31 pm Sale | 2023-12-31 | 13G | Dogness (International) Corporation DOGZ | SABBY MANAGEMENT, LLC | 63,636 11.000% | -40,303 (-38.78%) | Filing History |
| 2024-01-02 1:13 pm Sale | 2023-12-31 | 13G | Onconetix, Inc. ONCO | SABBY MANAGEMENT, LLC | 274 11.000% | -82 (-23.11%) | Filing History |
| 2024-01-02 10:24 am Unchanged | 2023-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX | SABBY MANAGEMENT, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-01-02 10:11 am Sale | 2023-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX | SABBY MANAGEMENT, LLC | 0 0.000% | -3,953 (Position Closed) | Filing History |
| 2024-01-02 09:53 am Sale | 2023-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT, LLC | 0 0.000% | -420,710 (Position Closed) | Filing History |
| 2024-01-02 09:42 am Sale | 2023-12-31 | 13G | Pulmatrix, Inc. PULM | SABBY MANAGEMENT, LLC | 182,249 11.000% | -119,689 (-39.64%) | Filing History |
| 2023-01-10 3:53 pm Sale | 2022-12-31 | 13G | AGM Group Holdings Inc. AGMH | SABBY MANAGEMENT, LLC | 12,559 11.000% | -17,310 (-57.95%) | Filing History |
| 2023-01-10 3:15 pm Sale | 2022-12-31 | 13G | Cingulate Inc. CING | SABBY MANAGEMENT, LLC | 2,351 11.000% | -1,341 (-36.32%) | Filing History |
| 2023-01-10 2:47 pm Sale | 2022-12-31 | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT, LLC | 796,706 11.000% | -434,124 (-35.27%) | Filing History |
| 2023-01-10 2:35 pm Purchase | 2022-12-31 | 13G | Tantech Holdings Ltd TANH | SABBY MANAGEMENT, LLC | 1,038 11.000% | 393 (+60.96%) | Filing History |
| 2023-01-10 2:21 pm Sale | 2022-12-31 | 13G | HeartBeam, Inc. BEAT | SABBY MANAGEMENT, LLC | 271,788 11.000% | -211,532 (-43.77%) | Filing History |
| 2023-01-10 2:10 pm Sale | 2022-12-31 | 13G | Recon Technology, Ltd. RCON | SABBY MANAGEMENT, LLC | 82,337 11.000% | -67,313 (-44.98%) | Filing History |
| 2023-01-10 1:49 pm Sale | 2022-12-31 | 13G | Bit Digital, Inc. BTBT | SABBY MANAGEMENT, LLC | 3,166,917 11.000% | -1,048,935 (-24.88%) | Filing History |
| 2023-01-10 1:36 pm Purchase | 2022-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX | SABBY MANAGEMENT, LLC | 3,953 11.000% | 445 (+12.70%) | Filing History |
| 2023-01-10 11:57 am Purchase | 2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | SABBY MANAGEMENT, LLC | 934,456 11.000% | 673,528 (+258.13%) | Filing History |
| 2023-01-10 11:40 am Sale | 2022-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT, LLC | 420,710 11.000% | -57,467 (-12.02%) | Filing History |
| 2023-01-10 11:21 am Purchase | 2022-12-31 | 13G | Pulmatrix, Inc. PULM | SABBY MANAGEMENT, LLC | 301,938 11.000% | 121,086 (+66.95%) | Filing History |
| 2023-01-10 10:14 am Unchanged | 2022-12-31 | 13G | Rebus Holdings, Inc. RBSH | SABBY MANAGEMENT, LLC | 0 0.000% | 0 (Unchanged) | Filing History |